Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2. This reflects a minor update to page metadata without altering study content or results.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedEnrollment has closed for this study, as indicated by the new 'No longer looking for participants' text. The page also includes updated navigation/help sections and a new version label (v3.6.0) reflecting a refreshed structure.SummaryDifference0.4%

- Check25 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a newer build of the site. This appears to be a maintenance update that does not alter the study content or its data on the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, representing a deployed update to the ClinicalTrials.gov interface without changing the study information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page has been updated to a new software/site revision (Revision v3.5.3 instead of v3.5.2). This reflects a version change rather than an update to the clinical study details.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.